Guanine Inc
Biotechnology ResearchNew York, United States2-10 Employees
Inventor of the electric oligonucleotide (eOligo). Guanine’s eOligo biosensor quantifies low concentration nucleic acids, proteins, small molecules, cells and redox materials in a single assay using an inexpensive test cartridge and mobile device. Our eOligo biosensor provide multi-analyte quantification, multiplexing, ultra-low LOD and high sensitivity and specificity by binding detection targets with millions of electroactive G, T, A or C oligonucleotide molecules on a sensor array. Magnetic separation and filter concentration of large sample volumes enhance test performance. Guanine’s affordable multiplex multi-analyte platform allows assay developers to develop multi-analyte blood tests for complex diseases at a fraction of the cost of lab tests. This will enables a new generation of advanced blood tests and precision health AI. Our upcoming sepsis infection test for ER physicians can reduce the time for correct antibiotics from 3 days to 1 hour without a culture. The company was Incubated at Mount Sinai’s Elementa Labs. Our predecessor company was spun out from NASA's Ames Research Center.
1-888-653-2347 
support@leadiq.com 
